Interestingly, NORAD has been proven to be overexpressed in a range of cancers, including pancreatic cancer [31] and bladder cancer [14]; in both cases, high expression of NORAD was associated with poor survival. The gene discussed is NORAD; the disease is urinary bladder carcinoma.